Abbreviations: ACh, acetylcholine; ACTX, atracotoxin; BCA, bicinchoninic acid; Bv8, 8kDa protein from the skin secretions of toads (Bombina variegata); CHO, Chinese hamster ovary; DDH, disulfidedirected -hairpin; EST, expressed sequence tag; FLIPR, fluorometric imaging plate reader; HEK, human embryonic kidney; ICK, inhibitory cystine-knot; MIT1, mamba intestinal toxin 1 from the venom of the black mamba snake Dendroaspis p. polylepis; PK, prokineticin (also known as endocrine-gland vascular endothelial growth factor or EG-VEGF); PKR, prokineticin receptor; RACE, rapid amplification of cDNA ends; TCEP, Tris(2-carboxyethyl)phosphine; TFA, trifluoroacetic acid. Atracinae), that appear to undergo N-and/or C-terminal post-translational modifications and conform to an ancestral protein fold. These peptides all show significant amino acid sequence homology to atracotoxin-Hvf17 (ACTX-Hvf17), a non-toxic peptide isolated from the venom of H. versuta, and a variety of AVIT family proteins including mamba intestinal toxin 1 (MIT1) and its mammalian and piscine orthologs prokineticin 1 (PK1) and prokineticin 2 (PK2). These AVIT family proteins target prokineticin receptors involved in the sensitization of nociceptors and gastrointestinal smooth muscle activation. Given their sequence homology to MIT1, we have named these spider venom peptides the MIT-like atracotoxin (ACTX) family. Using isolated rat stomach fundus or guinea-pig ileum organ bath preparations we have shown that the prototypical ACTX-Hvf17, at concentrations up to 1 GM, did not stimulate smooth muscle contractility, nor did it inhibit contractions induced by human PK1 (hPK1).
Introduction
Recently a novel non-toxic peptide was isolated from the venom of one of the world's most lethal group of arachnids, the Australian funnel-web spiders (Araneae: Hexathelidae: Atracinae) [42] . This 68-residue protein, ACTX-Hvf17, was isolated from the venom of the Blue Mountains funnel-web spider H. versuta. Interestingly, it does not function like classical funnel-web spider atracotoxins to modulate mammalian or insect voltage-gated ion channel function (for reviews see [35, 43] ) since it lacks insecticidal activity and fails to affect vas deferens smooth muscle or skeletal muscle contractility.
Despite some sequence homology with a variety of colipases it also lacks colipase activity. Accordingly we have been interested in identifying the target of ACTX-Hvf17.
We have recently determined that ACTX-Hvf17 shows significant sequence homology with a variety of novel peptides from fish, frog, snake and several mammalian species belonging to the AVIT family [19] as shown in Fig. 3 . This includes MIT1 from the venom of the black mamba snake Dendroaspis p. polylepis [2, 39] , Bv8 (Bombina variegata 8 kDa protein; [32] ) and its orthologs Bm8a-f (B. maxima 8 kDa protein; [4, 21] ) from the skin secretions of toads from Bombina spp., and the recently identified prokineticin 1 (PK1; also known as endocrine-gland vascular endothelial growth factor or EG-VEGF) and prokineticin 2 (PK2) peptides [27] . These are all 77-94 residue peptides, containing 10 cysteines with conserved spacing, whose N-terminal four residues, 'AVIT', are all identical (Fig. 3 ). All these peptides, including ACTX-Hvf17, display some limited sequence homology with a variety of colipases but lack colipase activity, are highly resistant to classical specific proteolytic enzymes, and have no overt toxic effects in vertebrates or insects [19, 42] . ACTX-Hvf17 shares 32% sequence identity with Bv8, including the 10 conserved cysteine residues, and is 44% homologous if conservative substitutions are included (Fig. 3) . The 3D fold of ACTX-Hvf17 remains undetermined as it is intractable to NMR analysis due to aggregation under a wide variety of conditions. Nevertheless, it is believed that ACTX-Hvf17 adopts the MIT1/colipase fold [42] . Recently two non-AVIT family peptides PRTx16C0 and PRTx16C1 with the highest reported homology to ACTX-Hvf17 have also been isolated from the venom of the Brazilian armed spider Phoneutria reidyi (SWISS-PROT data bank accession numbers P83893 and P83997) (Fig. 3) . Unfortunately, like ACTX-Hvf17, no target has yet been identified for these non-toxic arachnid peptides. This is not unique with only a few conotoxins within the venom of marine cone snails (Conus spp.) causing death or overt toxicity, requiring the target of the remaining peptides to be carefully determined.
AVIT family proteins are distributed widely in mammalian tissues and have been shown to cause a variety of actions. These include intestinal contraction [39] , hyperalgesia [32, 34] , spermatogenesis [48] , protection of neuronal cells from apoptosis [31] , control of behavioral circadian rhythms [5] and stimulation of endocrine gland angiogenesis [23] [24] [25] [26] . In particular MIT1, Bv8 and the prokineticins have all been shown to potently stimulate contraction of guinea-pig ileum smooth muscle with EC 50 values in the low to subnanomolar range [27, 32, 39] . However, they do not affect a range of other smooth muscle preparations including vas deferens, trachea, aorta, uterus, and gallbladder. Recent studies have shown that PK1 and PK2 are cognate ligands for two G-protein-coupled receptors designated ZAQ (PK1 receptor; PKR1) and I5E (PK2 receptor: PKR2), respectively [28, 29] . PK1 and PK2 induce a transient increase in intracellular calcium ([Ca 2+ ] i ) with nanomolar potency in Chinese hamster ovary (CHO) cells and human embryonic kidney (HEK293) cells expressing PKR1 and PKR2 receptors [28, 29] . They bind to these receptors with high affinity but PK2 has a higher affinity for both receptors than PK1.
In the present study we have identified six novel MIT-like ACTX orthologs using a combination of HPLC and molecular biology techniques. Given the homology to the AVIT protein family, we hypothesized that ACTX-Hvf17 and these MIT-like spider venom peptides stimulate nociceptors and gastrointestinal motility. Thus, these peptides may be useful compounds in the development of prokinetic agents in the treatment of conditions involving poor gastrointestinal motility, or novel analgesics. We show that while ACTX-Hfv17 shares sequence homology to AVIT family proteins and conforms to a similar ancestral protein fold, known as the disulfide-directed -hairpin, it lacks the ability to stimulate vertebrate gastrointestinal smooth muscle contractility. It also fails to bind to prokineticin receptors that mediate hyperalgesia and the prokinetic actions on smooth muscle. Modeling of the 3D structure of the MIT-like ACTX family and AVIT family proteins, based on the known structure of MIT1, revealed that the surface charges were also significantly different between these two families of peptides suggesting that the two families may target different receptors and are likely to be functionally distinct.
Materials and methods

Peptide purification
Venom was collected from both male and female specimens of the Australian funnel-web spider species H. sp. 20 ("Illawarra") and H. versuta, and female specimens of the Orchid Beach variant of H.
infensa (H. infensa: Orchid Beach) by aspirating venom from the fang-tips (chelicerae) of aggravated spiders into polyethylene pipette tips. Collected venom was dissolved in 0.1% TFA (v/v) for sample transfer to polyethylene tubes and dried down in a Savant SpeedVac for storage at -20°C.
ACTX-Hvf17 was isolated from H. versuta venom as described previously [42] . Lyophilized crude Hadronyche sp. 20 and H. infensa: Orchid Beach venoms were dissolved in 0.1% TFA (v/v) and components purified using an analytical C18 RP-HPLC column (4.6 x 250 mm, 300 Å pore size, 5 Gm particle size; Vydac, Hesperia, CA, USA). Venom peptides were eluted using an acetonitrile gradient (0-80% acetonitrile/0.1% TFA over 80 min) at a flow rate of 1 ml/min governed by a Waters 600
Controller. The UV absorbance was monitored at 214 nm using a Waters 486 tunable absorbance detector. Purified peptides were collected in polyethylene tubes, lyophilized, and stored at -20°C until required. The molecular mass of each peptide was confirmed by ESI-MS acquired in positive ion mode on a PE-SCIEX API III triple quadrupole mass spectrometer (PE-SCIEX, Canada) equipped with an
Ionspray atmospheric pressure ionization source and a Turbospray facility. The full scan data for each venom sample was acquired at an orifice potential of 80 V over a mass range of 400-2100 Da with a step size of 0.2 Da. Data is presented as the average mass in Da.
Toxin quantification was performed using a BCA (bicinchoninic acid) Protein Assay Kit (Pierce, Rockford, IL, USA) using BSA as a standard. Absorbances were read at 570 nm on a BIO-RAD Model 
N-terminal amino acid sequencing
The disulfide bonds of RP-HPLC purified native peptides were reduced using 100 mM TCEP in 100 mM ammonium acetate (pH 6.5) and heating at 45°C for 1 h. The reduced cysteine residues were alkylated using 100 mM maleimide/10% acetonitrile and heating at 45°C for 1 h. The reduced and alkylated peptides were isolated by elution on an analytical C 18 RP-HPLC column using Vydac 4.6 x 250 mm (see above) or Zorbax 2.1 x 50 mm (300 Å pore size, 3.5 µm particle size or 80 Å pore size, 5
Gm particle size; Hewlett Packard, Australia) columns. Partial amino acid sequences of the alkylated peptides were determined using Edman degradation chemistry on an Applied Biosystems 477A Protein 
Enzymic digestion of N-terminally blocked peptide components
Peptides determined to be N-terminally blocked from preliminary N-terminal amino acid sequencing were fragmented by enzymatic digestion with bovine pancreas trypsin (Sigma, Australia). The peptide fragments were eluted using an analytical RP-HPLC column (Zorbax 2.1 x 50 mm, 80 Å pore size, 5
Gm particle size) and an acetonitrile gradient (0-80% acetonitrile/0.1% TFA over 80 min) at a flow rate of 200 Gl/min. The solvent delivery and gradient formation was achieved using a Hewlett Packard Series 1100 HPLC pump system (Hewlett Packard). The UV absorbance of the eluting fragments was monitored at 210 nm and 280 nm using a Hewlett Packard Diode Array Detector. Amino acid sequencing was performed on an Applied Biosystems 477A Protein Sequencer.
mRNA Isolation and cDNA library formation
The venom glands of anaesthetized mature and juvenile male H. sp. 20, and a female H. infensa:
Orchid Beach specimens were dissected and the mRNA purified using a Pharmacia Biotech Quickprep containing the correct insert size were sequenced (AGRF).
Expressed sequence tag library
The PCR products of the female H. infensa: Orchid Beach sample were cleaned on a Bresatec PCR purification column, cut with NotI (MBI Fermentas, Hanover, MD, USA), re-cleaned using Bresa-Clean and transformed into TOP10f' cells (Invitrogen). Clones containing the correct insert size were sequenced (AGRF).
Molecular modeling
The ACTX-Hvf17, ACTX-Hi:OB75212, ACTX-Hs20f7358, Bv8, rPK1 and rPK2 models were constructed using the Homology program within the Insight II molecular modeling system from Accelrys. The amino acid sequences of MIT1 (Boisbouvier et al., 1998) , ACTX-Hvf17 (Szeto et al, 2000) , ACTX-Hi:OB7512 (this paper), ACTX-Hs20f7358 (this paper), Bv8 [32] , rPK1 and rPK2 [29] were aligned within Homology where the alignment was refined using predicted structurally conserved regions of MIT1 defined by PROMOTIF [15] . Refining the models involved repairing splice points such that angles and corresponding bond distances were 180 ± 1˚and 1.34 Å, respectively. The models were then minimized using steepest descents and conjugate gradients taking into account morse and cross terms and charges to a rmsd below 10 -6 kcal/mol-Å. Finally, the models were validated using the programs Profiles 3D (within the Homology program) and Procheck [33] .
Isolated smooth muscle preparations
All animal experimentation was approved by the Animal Care and Ethics Committees of the University of Technology, Sydney and Monash University. Given the lack of H. sp. 20 and H. infensa:
Orchid Beach spiders and thus sufficient venom for pharmacological investigations, experiments were only carried out with ACTX-Hvf17.
Isolated guinea-pig ileum smooth muscle preparation
Dunkin-Hartley guinea-pigs (0.5-1.3 kg), of either sex, were sacrificed by dislocation of cervical vertebrae. Segments of ileum (2-3 cm), dissected 10 cm distal to the ileo-caecal junction, were then dissected and attached to electrodes. These were mounted in 5 ml isolated organ baths in a Krebs solution of the following composition (mM): NaCl 118.4, KCl 4.7, MgSO 4 1.2, KH 2 PO 4 1.2, CaCl 2 2.5, NaHCO 3 25.0 and D-glucose, 11.1. The solution was maintained at 34°C and bubbled with carbogen (95% O 2 and 5% CO 2 ). For electrically stimulated preparations, ilea were transmurally stimulated by regular field pulses (40 V, 0.5 ms, 0.2 Hz) using a Grass S88 stimulator. 
Isolated rat stomach fundus and aorta smooth muscle preparations
Contractility studies
Isometric muscle tension was recorded with a force-displacement transducer (Nihon Kohden SB-1T, Tokyo, Japan) on a polygraph (Nihon Kohden) or a Grass transducer (FTO3) connected to a Grass polygraph (Model 79D). Data were also digitized using a MacLab 4/s or Powerlab/400 data acquisition system (ADInstruments, Castle Hill, Sydney, Australia). Each preparation was placed under an initial resting tension of 1 g and allowed to equilibrate for 1 h before experimental procedures were carried out.
Muscle tension in each tissue was recorded in the absence of additives or following injection of peptides (5-20 Gl in water) directly into the bath buffer. To confirm stable contractions of sufficient amplitude, contractions of smooth muscle preparations to 1 GM ACh (ileum and fundus) or 50 mM KCl (aorta)
were checked before addition of ACTX-Hvf17 or vehicle, and at the conclusion of the experiment. To determine if ACTX-Hvf17 blocked contractions mediated via prokineticin receptors, responses to recombinant hPK1 (Peprotech, Princeton, NJ, USA) were measured before, and following, addition of ACTX-Hvf17.
Calcium-mobilization assay using a fluorometric imaging plate reader (FLIPR)
Assessment of ACTX-Hvf17 function on prokineticin receptors was accomplished using a according to the manufacturer's protocol. ACTX-Hvf17 was added at the indicated concentrations and the elevation in fluorescence, in proportion to an increase in [Ca 2+ ] i , was monitored. In cases where ACTX-Hvf17 was tested for antagonist activity the initial exposure to the spider peptide was followed five minutes later by the introduction of 10 nM recombinant hPK1 (Peprotech).
Chemicals
Unless otherwise stated, all chemicals were of analytical grade and were purchased from Sigma-Aldrich Chemical Co. (St Louis, MO, U.S.A.).
Statistical analysis
Numerical data are presented as the mean ± S.E. (n, number of observations). Statistical differences were determined using a Student's paired t-test, at P < 0.05.
Results
Isolation of a novel family of spider peptides with sequence homology to the MIT-like ACTX-Hvf17
Components 
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was predicted to be an isoform of the 7406.2 Da component. As a result it was anticipated that both components would be identified from the use of a single 3' RACE primer. Due to the expected sequence characterisation of both components in the molecular biology experiments, enzymatic digestion was not performed on the 7390.0 Da fraction. and ACTX-Hs20f7406 were easily identified in the RP-HPLC/ESI-MS data (Fig. 1A) , however the third component ACTX-Hs20f7418 was not evident. It is possible that the component ACTX-Hs20f7418 is expressed at levels below the level of detection on the mass spectrometer and as a result is not evident in the RP-HPLC/ESI-MS data.
Sequence identification of MIT-like ACTX peptides using RACE
R e v i e w C o p y
The Expressed Sequence Tag (EST) technique identified the presence of a MIT-like ACTX in the venom of Hadronyche infensa: Orchid Beach.
During the course of the studies on MIT-like ACTX components, a further component belonging to this family, ACTX-Hi:OBf7512 (GenBank accession number AY914163), was identified from the venom glands of a female Hadronyche infensa: Orchid Beach specimen using Expressed Sequence Tag (EST) techniques (Fig. 2A) . The sequence information provided a mature peptide sequence containing an identical C-terminal tail (Arg-Ser-Glu) to some of the sequences of this family derived from the RACE experiments (Fig. 2B) . It was anticipated, based on molecular weight calculations, that these Cterminal residues were post-translationally cleaved to produce the mature product.
The calculated theoretical molecular weight of the fully cleaved mature product, accounting for the formation of five disulfide bonds and C-terminal tail cleavage, was 7586. ACTX-Hvf17, two non-toxic spider peptides from the venom of the spider P. reidyi, and to a lesser extent, AVIT family proteins (Fig 3) .
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Effect of ACTX-Hvf17 on gastrointestinal and vascular smooth muscle
Previously, ACTX-Hvf17 has been screened for mammalian bioactivity using a rat vas deferens bioassay [42] . In this previous study it was found that the peptide lacked any observable activity in this smooth muscle preparation. Given the potential activity of the peptide on other smooth muscle preparations, particularly gastrointestinal tissue, the present study therefore tested the activity of ACTXHvf17 on isolated ileum and stomach fundus, as well as aorta. As shown in Fig. 4 , ACTX-Hvf17 at concentrations up to 1 GM had no effect on gastrointestinal smooth muscle. This was evidenced by a lack of change in resting (baseline) tension of isolated guinea-pig ileum longitudinal muscle (n = 3; Fig.   4Ab ) and rat stomach fundic muscle strip preparations (n = 6; Fig. 4B ). In addition, ACTX-Hvf17 failed to alter stimulated contractions of guinea-pig ileum (n = 3; Fig. 4Aa ). Furthermore, ACTX-Hvf17 (1 GM) failed to affect the resting tension of isolated aortic smooth muscle preparations (n = 3, Fig. 4C) indicating that the peptide does not directly stimulate vascular smooth muscle.
To investigate the possible antagonism of prokineticin receptors by ACTX-Hvf17, smooth muscle strips from rat stomach fundus and guinea-pig ileum were contracted with hPK1 and ACTX-Hvf17 added 10 min before a second challenge of hPK1. At concentrations of hPK1 up to 10 nM, hPK1 only caused contractions in 3 out of 6 fundic strips. The contractile responses in these 3 tissue strips were only around 20% of the responses elicited by 1 GM ACh. In addition, following the first application of hPK1, a strong tachyphylaxis developed such that additional applications of hPK1 did not result in any contraction. It was thus not possible to obtain a reproducible response to hPK1 in these preparations.
This strong tachyphylaxis supports the observation by Mollay et al. (1999) who demonstrated that an intense tachyphylaxis developed after the first exposure of MIT1 and Bv8 to jejunum and colon. In contrast, hPK1 produced reproducible dose-dependent responses in guinea-pig ileum. However, concentrations of ACTX-Hvf17 up to 1 GM failed to alter the amplitude of these contractions, signifying that the peptide does not block prokineticin receptors in guinea-pig ileum (P > 0.9, n = 3; Fig. 4Ac ).
Effects of ACTX-Hvf17 on expressed prokineticin receptors
To directly evaluate the effect of ACTX-Hvf17 on prokineticin receptors, we assessed the increase in ] i in cells expressing either hPKR1 (Fig. 5A ) or hPKR2 receptors (data not shown). ] i (Fig. 5B) . These data indicate that ACTX-Hvf17 lacks both agonist and antagonist activity at hPKR1 and hPKR2 receptors.
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Molecular modeling of MIT-like ACTX
The 3D structures of the MIT-like ACTXs, Bv8, PK1 or PK2 have not yet been solved. ACTXHvf17 aggregates under a wide variety of solvent conditions at concentrations sufficient for NMR making NMR structural analysis futile [42] , whereas structural analysis on the other peptides has not yet been attempted. However, the 3D structure of MIT1 has been determined ( Fig. 6A) and despite a low level of sequence homology, was found to be very similar to porcine colipase [2, 45] . Given the overall sequence homology between MIT-like ACTX, Bv8, PK1, PK2, MIT1 and to a lesser extent colipase, including the conserved cysteine residues and resistance to proteolytic digestion [2] , MIT-like ACTX, Bv8, PK1 and PK2 were proposed to have the same 3D folds as MIT1 and colipase [42] . Modeling of the ACTX-Hvf17, ACTX-Hi:OBf7512, ACTX-Hs20f7358, Bv8, rPK1 and rPK2 structures based on MIT1, as shown overlaid in Fig. 6B (ACTX-Hvf17 only), reveals that the structurally conserved regions of the putative 3D structure of ACTX-Hvf17, ACTX-Hi:OBf7512, ACTX-Hs20f7358, Bv8, rPK1 and rPK2 are indeed very similar to those of the MIT1 and colipase peptides. This is not surprising given that all 10 cysteine residues align closely between the eight peptides even though the primary sequence is not identical in length. Additionally, loop 3 in all peptides aligns well to MIT1 having an rmsd over the backbone atoms of approximately 0.36 Å. However, models displaying the electrostatic surface potential revealed that MIT-like ACTX peptides do not share similar surface charge distribution as AVIT family proteins (Fig. 6C-D) . In addition, while the AVIT family proteins share a comparable surface polarity distribution the MIT-like ACTX peptides do not (Fig. 6C-D) .
ACTX-Hvf17 conforms to the DDH ancestral protein fold
Previously, MIT1, colipase, and a wide variety of other eukaryotic proteins, have been characterized as comprising a disulfide-directed -hairpin (DDH) fold [47] , as shown in Fig. 7Aa . The amino acid consensus sequence of the DDH fold can be written as CX 5-9 CX 2 [G or P]X 2 CX 6-19 C, where X is any amino acid [47] . A strictly conserved central Gly or Pro is also present in loop 3, which ensures a tight turn prior to the first -stand (Fig. 6A-B) . In general, hydrophobic residues also tend to follow the central Gly/Pro in loop 3. The inhibitor cystine-knot (ICK) motif present in all ACTX structures
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determined to date appears to have evolved from this simpler ancestral fold [47] . In contrast to the ICK motif, which has not been found in vertebrates and includes a triple-stranded antiparallel -sheet (Fig.   7Ab ), the DDH fold is found in a variety of eukaryotes, has no requirement for an N-terminal -strand, and only two mandatory disulfide bridges form the bulk of the hydrophobic core of this domain.
Importantly, we observed a homologous DDH domain in all the MIT-like ACTX and the P. reidyi spider peptides PRTx16C0 and PRTx16C1 (Fig. 7B ). In addition, there is a strong conservation of residues in loop 3 between the MIT-like ACTX, the P. reidyi spider peptides and the AVIT family of proteins with a consensus sequence of CGXGXCC, where X is any amino acid. Therefore it appears that MIT-like ACTXs, PRTx16C0, PRTx16C1, Bv8, MIT1, and the various prokineticins may have arisen from simple gene duplication followed by minor residue changes in the intervening loops (Fig. 7B ). In the case of MIT-like ACTXs and the P. reidyi peptides, however, they appear to have undergone the greatest alteration or deletion of loop residues, particularly in the N-terminal and loop 4 regions, resulting in loss of activity on prokineticin receptors.
The DDH motif of the MIT-like ACTX differs from other DDH members by having only four residues following the first cysteine in the amino acid consensus sequence. Furthermore, huwentoxin-II (Shu et al., 2002) , another spider peptide conforming to the DDH fold, only has four residues preceding the last cysteine in the amino acid consensus sequence (Fig. 7B) . Hence the consensus sequence needs to be modified to CX 4-19 CX 2 [G or P]X 2 CX 4-19 C. However, the presence of five residues in loop 3 with a central Gly residue in virtually all cases, exclude the possibility that the MIT-like ACTXs adopt the cystine-stabilized -sheet (CSB) motif [14] . In the CSB fold the number of residues in loop 3 can be as low as two and there is no requirement for a central glycine residue.
Discussion
Through a combined approach of amino acid sequencing and molecular biology techniques, five homologous components were isolated from the venom of H. sp. 20. An additional ortholog was also identified from the venom of H. infensa: Orchid Beach using EST molecular biology techniques. With the exception of the component ACTX-Hs20f7418 from H. sp. 20 venom, all molecules were accounted for in their respective venom RP-HPLC/ESI-MS profiles (Fig. 1) . This family of peptides shows high amino acid sequence homology with each other particularly in the leader sequence (Fig. 2B) . In addition, they all show high sequence homology with ACTX-Hvf17 from H. versuta venom [42] and to a lesser extent PRTx16C0 and PRTx16C1 from the venom of the spider P. reidyi. Like ACTX-Hvf17, the target of these peptides and those from P. reidyi venom is yet unknown.
ACTX-Hvf17, and the orthologous peptides identified in the present study, also show significant R e v i e w C o p y sequence homology with MIT1. Hence we have termed this group of non-toxic atracotoxins the 'MITlike' ACTX family. MIT1 belongs to the 'AVIT' protein family including Bv8 and orthologs from the PK1/EG-VEGF and PK2 families [19] . All AVIT family members that have been tested so far stimulate contraction of fundus and ileum smooth muscle via interaction with prokineticin receptors. Therefore, we determined if MIT-like ACTX interacted with prokineticin receptors to increase gastrointestinal smooth muscle contractility.
Unlike AVIT proteins, this study showed that the prototypical MIT-like ACTX, ACTX-Hvf17, does not stimulate gastrointestinal smooth muscle contractility as evidenced by a lack of activity on stimulated guinea-pig ileum and rat stomach fundus. Neither did the peptide affect responses of ileum smooth muscle to ACh. In addition, the peptide failed to contract other smooth muscle preparations including rat aorta. We also assessed the ability of ACTX-Hvf17 to act as a prokineticin receptor antagonist by determining the ability of the peptide to inhibit hPK1-induced contractions of gastrointestinal smooth muscle. We were unable to assess the effects on hPK1-induced contractility in fundus and aorta due to the inconsistent response and strong tachyphylaxis of hPK1 in these tissues.
Nevertheless, ileal muscle contractions elicited by 4 nM hPK1 were unaffected by 1 GM ACTX-Hvf17.
In addition to experiments performed on isolated smooth muscle, we also investigated the effects of ACTX-Hvf17 on hPKR1 and hPKR2 receptors expressed in HEK293 cells. These are orphan G-proteincoupled receptors that are present on various mammalian cells and were found to bind AVIT family proteins. Receptor activation leads to an increase in [Ca 2+ ] i , as well as an increased phosphoinositide turnover, and activation of the p44/p42 mitogen-activated protein kinase signaling pathway (for a review see [19] ). These actions are consistent with the effects of prokineticins on smooth muscle contractility and angiogenesis. Using a FLIPR assay, ACTX-Hvf17 at concentrations up to 100 nM failed to cause an increase in [Ca 2+ ] i indicating that the peptide lacks agonist activity on both hPKR1 and hPKR2 receptors.
In addition, increasing concentrations of ACTX-Hfv17 up to 100 nM failed to inhibit the hPK1-induced increase in [Ca 2+ ] i signifying that ACTX-Hf17 lacks antagonist activity on both PKR1 and PKR2
receptors. In concert, the results from the FLIPR assay and isolated smooth muscle preparations indicate that ACTX-Hvf17 does not bind to either PKR1 or PKR2 receptors despite sequence homology to the AVIT family proteins. The PK2 protein is not commercially available so we were unable to test this protein in these assays. It therefore remains a possibility that ACTX-Hfv17 can block the PK2 interaction with the receptors, although this is unlikely given the overlap in efficacy of PK1 and PK2 at prokineticin receptors. It is also possible that prokineticin receptors exist in prey species that differ significantly from those found in vertebrates and that the MIT-like peptides show phyla-specificity for these targets. Nevertheless no overt toxicity or behavioural changes were noted following injection of
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Modeling of the electrostatic surface potential of the MIT-like ACTX family based on the known structure of MIT1 reveals that the surface charge distribution is distinct from the AVIT family. Indeed, while the surface charge distribution within the AVIT family appear to be comparatively similar, the electrostatic surface maps of the MIT-like ACTX family appear quite inconsistent between members.
This adds further support to the finding that the MIT-like ACTX fail to bind to PKR1 or PKR2 receptors.
Interestingly, one notable sequence characteristic of these MIT-like arachnid venom peptides is that they all appear to lack the characteristic N-terminal AVITG[A or V]C sequence of AVIT proteins, suggesting a functional role for this region. Furthermore, there is considerable lack of sequence homology in loop 4 (e.g. Ser 15 -His 21 in ACTX-Hvf17). Unfortunately little is known about the structure-function relationships of AVIT protein family members, however it is unlikely that the C-terminal domain plays a significant role in the activity of this family of peptides since there is considerable sequence variability in the C-termini beyond the last Cys residue. It is also unlikely that the residues in loop 3 are important for activity given the high homology with the inactive ACTX-Hvf17 peptide. Experiments with Nterminal truncates could therefore help to address any functional importance of the N-terminus, especially the first five to six residues, of the AVIT family of proteins.
Given the likelihood that these venom peptides and the AVIT proteins share the ancestral DDH fold motif it is conceivable that the two groups, and other proteins such as colipase, evolved from a very ancient ancestor. However, following the period of the chordate-arthropod divergence around 1000 million years ago [46] , the mutations in the primary sequence, possibly in the N-terminus and/or loop 4, resulted in the loss of activity on prokineticin receptors. These could be due to positive selection for adaptive changes as part of a general evolution of the gastroenteropanceatic hormonal system in mammals. That is why the functional constraints for the AVIT proteins are practically unchanged in all lineages. Nevertheless, an alternative theory is that spider peptides and AVIT proteins evolved separately. Given that the DDH fold is present in plants (e.g. gurmarin) as well as invertebrates (e.g.
spider venom peptides) it can be argued that they evolved independently rather than from a pancreatic origin as suggested by Boisbouvier et al. (1998) . In support ACTX-Hvf17, colipases, and MIT1 are highly resistant to proteases and convergent evolution may have arisen because the DDH fold is an efficient way to construct a tight globular protein that is resistant to proteolysis. This has been as previously argued for the more elaborate, but related, ICK motif [10] (Fig. 7Ab) .
Based on the partial N-terminal sequencing data of ACTX-Hs20f7358 and the published sequence of ACTX-Hvf17 [42] , cleavage of the mature peptides from the leader sequences is expected to occur following the residues Ser-Ala for the components ACTX-Hs20f7418, ACTX-Hs20f7406 and ACTX-
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Hs20f7390 and residues Phe-Ala for molecules ACTX-Hi:OBf7512, ACTX-Hs20f7358 and ACTXHs20f7496 (Fig 2B-C) . These cleavage sites are different to the "classical" prohormone cleavage recognition site Lys-Arg between a propeptide and mature-peptide [38] , but are consistent with the signal peptide cleavage sites predicted using SignalP (v3.0) [1] and those of the AVIT peptide family [32, 48] . Importantly, this leader sequence configuration is unlike other neurotoxic ACTX belonging to the -1, -1, -2 and 1 ACTX families [41] , where the leader sequence comprises of a signal sequence followed by a propeptide, with the propeptide being cleaved to form the mature-peptide.
Although no literature reports of mature-peptide cleavage following the residues Ser-Ala were found, cleavage of the mature-peptide from the leader sequence for the spider venom peptide latrodectin from the Mediterranean black widow spider (Latrodectus tredecimguttatus) was found to occur following the residues Phe-Ala [37] . The latrodectin leader sequence is identical in length and similar in sequence to the leader sequence of the MIT-like ACTX family; 28% identity increasing to 67-78% homology if conservative substitutions are included. Numerous examples of leader sequences composing only a signal peptide have also been reported for scorpion toxins [3] . Despite the homology shared in the leader sequences, the mature MIT-like ACTX peptide sequences have no notable homology with the mature latrodectin sequence. It is also notable that, like the MIT-like ACTX family, no functional activity has been determined for latrodectin. The leader sequences of Bv8 and its mammalian orthologs hBv8 and mBv8 also lack a propeptide region and display some sequence similarity with the leader sequences determined for MIT-like ACTX peptides, however they are more variable than the leader sequence for latrodectin (17-22% identity, and 39-56% similarity if conservative substitutions are included) [32, 48] .
All the novel peptide components, except ACTX-Hs20f7358, were concluded to undergo post-translational modifications involving N-terminal pyroglutamate formation and/or C-terminal "trimming". Despite this not being reported for other ACTX peptides, post-translational pyroglutamate formation has been described with contulakin-G from the cone snail Conus geographus [7] , several members of the charybdotoxin-like -KTx 1 subfamily of scorpion toxins (for a review see [44] ) and dendrotoxin from the mamba Dendroaspis augusticeps [8] . C-terminal trimming has also been reported for a number of peptide toxin components, including the spider toxins Tx1, Tx3-2 and Pn3A from the Brazilian armed spider P. nigriventer [9, 17] , the bee toxin melittin [20] , -CTX GVIA from C.
geographus [6] and the scorpion toxins AaHI, AaI', AaHII and AaHIII [3] from the scorpion
Androctonus australis hector.
In conclusion, we report the identification of a group of novel atracotoxin peptides, the MIT-like ACTX family, with novel leader sequence structure that appear to undergo post-translational modification. The results of the present study also illustrate that the prototypical MIT-like atracotoxin,
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ACTX-Hvf17, does not increase smooth muscle contractility. This finding, coupled with a previous report that it does not act as a colipase [42] , suggest that the peptide and other MIT-like ACTXs are not involved in prey digestion. In addition, the finding that the peptide fails to interact with prokineticin receptors, targeted by AVIT family proteins negates the possibility that MIT-like ACTX act as hyperalgesic agents to sensitize nociceptors and increase pain in prey species [32, 34] . Modeling of the 3D structure of the MIT-like ACTX and AVIT family proteins also indicates that these two groups do not share similar surface distribution, further supporting the finding that MIT-like ACTX lack affinity for prokineticin receptors. Therefore, the role of MIT-like ACTXs in the venom of funnel-web spiders remains unknown. Sequence identities relative to ACTX-Hvf17 are shown in grey boxes, while conservative substitutions are in grey italic text. Lines connecting pairs of Cys residues above the sequences indicate the disulfide bonds determined for MIT1. Abbreviations: PRTx16C0 and PRTx16C1, non-toxic peptides from the spider P. reidyi (SWISS-PROT data bank accession numbers P83893 and P83997); Bv8 and Bm8, skin secretion proteins from the toad Bombina variegata and B. maxima, respectively [4, 21, 32] ; MIT1 [16, 39] ; PK1 and PK2, prokineticin 1 and 2, respectively. Prefixes: r, rat [29] ; m, mouse; and h, human [22, 27, 48] ; b, bovine (GenBank accession number AY192558) and f, fugu (see [19] ). All mammalian and piscine prokineticin sequences are deduced from cloned cDNAs. The lower right table shows the peptide length as well as % identity and homology (including conserved substitutions) relative to ACTX-Hvf17. 
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